BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34811925)

  • 1. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
    Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
    Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
    Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
    Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
    Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
    Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher TIGIT
    Jin Z; Lan T; Zhao Y; Du J; Chen J; Lai J; Xu L; Chen S; Zhong X; Wu X; Li Y
    Immunol Invest; 2022 Jan; 51(1):40-50. PubMed ID: 32819181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of TIGIT
    Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
    Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher TIGIT+ γδ T
    Hou Q; Wang P; Kong X; Chen J; Yao C; Luo X; Li Y; Jin Z; Wu X
    Front Immunol; 2024; 15():1321126. PubMed ID: 38711501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 and TIGIT Are Highly Co-Expressed on CD8
    Xu L; Liu L; Yao D; Zeng X; Zhang Y; Lai J; Zhong J; Zha X; Zheng R; Lu Y; Li M; Jin Z; Hebbar Subramanyam S; Chen S; Huang X; Li Y
    Front Oncol; 2021; 11():686156. PubMed ID: 34490086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
    Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
    Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
    Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
    Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes.
    Liu Z; Guo Y; Huang L; Jia Y; Liu H; Peng F; Duan L; Zhang H; Fu R
    Cell Commun Signal; 2022 Oct; 20(1):169. PubMed ID: 36303184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
    Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
    Liu G; Zhang Q; Yang J; Li X; Xian L; Li W; Lin T; Cheng J; Lin Q; Xu X; Li Q; Lin Y; Zhou M; Shen E
    Cancer Immunol Immunother; 2022 Feb; 71(2):277-287. PubMed ID: 34129052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
    Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
    Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of Costimulatory Molecule Tim3 on NK Cells and Its Subsets in Patients with Acute Myeloid Leukemia].
    Wu WH; Shao JW; Jiang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1899-1903. PubMed ID: 33283717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
    Front Immunol; 2021; 12():665541. PubMed ID: 33986753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia.
    Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Sanchez-Correa B; Guerrero B; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Sanchez-Garcia J; Serrano J; Martin C; Duran E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764229
    [No Abstract]   [Full Text] [Related]  

  • 19. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
    Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
    Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
    Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
    J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.